GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Oneness Biotech Co Ltd (LUX:ONEA) » Definitions » Debt-to-Revenue

Oneness Biotech Co (LUX:ONEA) Debt-to-Revenue : 4.15 (As of Mar. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Oneness Biotech Co Debt-to-Revenue?

Debt-to-Revenue measures a company's ability to pay off its debt.

Oneness Biotech Co's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was $1.30 Mil. Oneness Biotech Co's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was $12.23 Mil. Oneness Biotech Co's annualized Revenue for the quarter that ended in Mar. 2024 was $3.26 Mil. Oneness Biotech Co's annualized Debt-to-Revenue for the quarter that ended in Mar. 2024 was 4.15.


Oneness Biotech Co Debt-to-Revenue Historical Data

The historical data trend for Oneness Biotech Co's Debt-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Oneness Biotech Co Debt-to-Revenue Chart

Oneness Biotech Co Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Debt-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.01 24.40 7.29 4.32 0.25

Oneness Biotech Co Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Mar24
Debt-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.46 2.91 3.26 3.32 4.15

Competitive Comparison of Oneness Biotech Co's Debt-to-Revenue

For the Biotechnology subindustry, Oneness Biotech Co's Debt-to-Revenue, along with its competitors' market caps and Debt-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Oneness Biotech Co's Debt-to-Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Oneness Biotech Co's Debt-to-Revenue distribution charts can be found below:

* The bar in red indicates where Oneness Biotech Co's Debt-to-Revenue falls into.



Oneness Biotech Co Debt-to-Revenue Calculation

Debt-to-Revenue measures a company's ability to pay off its debt.

Oneness Biotech Co's Debt-to-Revenue for the fiscal year that ended in Dec. 2022 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(0.436 + 8.159) / 34.762
=0.25

Oneness Biotech Co's annualized Debt-to-Revenue for the quarter that ended in Mar. 2024 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(1.296 + 12.225) / 3.256
=4.15

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-Revenue, the Revenue of the last fiscal year is used. In calculating the annualized quarterly data, the Revenue data used here is four times the quarterly (Mar. 2024) Revenue data.


Oneness Biotech Co Debt-to-Revenue Related Terms

Thank you for viewing the detailed overview of Oneness Biotech Co's Debt-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Oneness Biotech Co (LUX:ONEA) Business Description

Traded in Other Exchanges
Address
No. 236, Section 4, Xinyi Road, 11th Floor, Daan District, Taipei, TWN, 106
Oneness Biotech Co Ltd is a Taiwan based biopharmaceutical company. The company develops healthcare drugs. Its products are used for chronic diabetic, dengue hemorrhagic fever, and Rheumatoid Arthritis. The company's operating segment includes New Drug Research and Development and Agricultural Products Cultivation. It generates maximum revenue from New Drug Research and Development segment.

Oneness Biotech Co (LUX:ONEA) Headlines

No Headlines